Some of the above-depicted lncRNAs with cancer SNPs, deletions and amplifications, such as HOTAIR, ANRIL, or MALAT1 were implicated in the development of treatment-resistant cancer cells (Liu et al., 2020). The gene discussed is CDKN2B-AS1; the disease is cancer.